Long term survival of GOG 252 'randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/GOG study' Meeting Abstract
| Authors: | Walker, J.; Mark, B.; Moore, K.; Tewari, K.; Thaker, P.; DiSilvestro, P.; Van Le, L.; Guntupalli, S.; Gray, H.; Rose, P.; Alberts, D.; Fujiwara, K.; Mannel, R.; Aghajanian, C.; Copeland, L.; Fleming, G. |
| Abstract Title: | Long term survival of GOG 252 'randomized trial of intravenous versus intraperitoneal chemotherapy plus bevacizumab in advanced ovarian carcinoma: An NRG oncology/GOG study' |
| Meeting Title: | 2022 Society of Gynecologic Oncology Annual Meeting |
| Journal Title: | Gynecologic Oncology |
| Volume: | 166 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Mar 18-21 |
| Meeting Location: | Phoenix, AZ |
| ISSN: | 0090-8258 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2022-08-01 |
| Start Page: | S16 |
| End Page: | S17 |
| Language: | English |
| ACCESSION: | WOS:000892325300023 |
| PROVIDER: | wos |
| DOI: | 10.1016/S0090-8258(22)01239-2 |
| Notes: | Meeting Abstract: 021 -- Source: Wos |
